Immunostimulatory activity of Y-shaped DNA nanostructures mediated through the activation of TLR9

Biomed Pharmacother. 2019 Apr:112:108657. doi: 10.1016/j.biopha.2019.108657. Epub 2019 Feb 21.

Abstract

Immunostimulatory oligodeoxynucleotides (DNAs) have been widely studied in pharmaceutical and biomedical research fields for applications in cancer immunotherapy and vaccination. Toll-like receptors (TLRs) are critical for the instruction and orchestration of the host immune system composed of innate and adaptive immunity. In particular, TLR9 responds to DNAs with unmethylated deoxycytosine-deoxyguanosine (CpG) motifs, thereby inducing the activation of innate immune cells, such as dendritic cells, and consequently, adaptive immune cells. In this study, we developed two kinds of Y-shaped double-stranded DNA nanostructures (Y-DNAs), including a single unit composed of three DNA strands (YS-DNA) and a ligated multiunit complex formed by crosslinking each YS-DNA (YL-DNA), and investigated whether they have immunostimulatory activity in innate immune cells. YS-DNA and YL-DNA induced the production of immune cytokines such as IL-12 and TNF-α and the expression of costimulatory molecules such as CD80 and CD86 in primary mouse dendritic cells and macrophage cells (RAW264.7 cells). A Coprecipitation study demonstrated that YL-DNA was directly associated with TLR9. The induction of immune cytokines by YS-DNA and YL-DNA was abolished in TLR9-deficient primary mouse dendritic cells. The results demonstrated that Y-DNAs induced the activation of dendritic cells and macrophages mediated by the activation of TLR9, as shown by the expression of immune cytokines and costimulatory molecules. The results suggest that Y-DNA nanostructures provide a beneficial strategy for immunotherapy by modulating the immune system.

Keywords: Immunostimulatory DNA; Nanostructures; Pattern recognition receptor; Toll-like receptor.

MeSH terms

  • Animals
  • DNA / administration & dosage
  • DNA / chemistry*
  • DNA / immunology
  • HEK293 Cells
  • Humans
  • Immunity, Cellular / drug effects*
  • Immunity, Cellular / physiology
  • Inflammation Mediators / immunology
  • Inflammation Mediators / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Nanostructures / administration & dosage
  • Nanostructures / chemistry*
  • Oligodeoxyribonucleotides / administration & dosage
  • Oligodeoxyribonucleotides / chemistry*
  • Oligodeoxyribonucleotides / immunology
  • Toll-Like Receptor 9 / immunology
  • Toll-Like Receptor 9 / metabolism*

Substances

  • Inflammation Mediators
  • Oligodeoxyribonucleotides
  • Tlr9 protein, mouse
  • Toll-Like Receptor 9
  • DNA